Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy.

@article{Carandang2016ThirtyYA,
  title={Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy.},
  author={Raphael A Carandang},
  journal={JAMA neurology},
  year={2016},
  volume={73 3},
  pages={265-7}
}